RU2018128415A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018128415A3 RU2018128415A3 RU2018128415A RU2018128415A RU2018128415A3 RU 2018128415 A3 RU2018128415 A3 RU 2018128415A3 RU 2018128415 A RU2018128415 A RU 2018128415A RU 2018128415 A RU2018128415 A RU 2018128415A RU 2018128415 A3 RU2018128415 A3 RU 2018128415A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018128415A RU2761824C2 (ru) | 2018-08-03 | 2018-08-03 | Ингибиторы CDK8/19 |
| EA202190452A EA202190452A1 (ru) | 2018-08-03 | 2019-07-31 | Ингибиторы cdk8/19 |
| MA52375A MA52375B2 (fr) | 2018-08-03 | 2019-07-31 | Inhibiteurs de cdk8/19 |
| PE2021000162A PE20210416A1 (es) | 2018-08-03 | 2019-07-31 | Inhibidores de ckd8/19 |
| CA3108298A CA3108298A1 (en) | 2018-08-03 | 2019-07-31 | Cdk8/19 inhibitors |
| BR112021001939-1A BR112021001939A2 (pt) | 2018-08-03 | 2019-07-31 | inibidores de cdk8/19 |
| AU2019313199A AU2019313199B2 (en) | 2018-08-03 | 2019-07-31 | CDK8/19 inhibitors |
| KR1020217006527A KR102926889B1 (ko) | 2018-08-03 | 2019-07-31 | Cdk8/19 저해제 |
| JP2021505964A JP7365396B2 (ja) | 2018-08-03 | 2019-07-31 | Cdk8/19阻害薬 |
| EP19844331.9A EP3831829A4 (en) | 2018-08-03 | 2019-07-31 | CDK8/19 INHIBITORS |
| MX2021001335A MX2021001335A (es) | 2018-08-03 | 2019-07-31 | Inhibidores de ckd8/19. |
| US17/264,670 US11840531B2 (en) | 2018-08-03 | 2019-07-31 | CDK8/19 inhibitors |
| CN201980065665.1A CN113166140B (zh) | 2018-08-03 | 2019-07-31 | Cdk8/19抑制剂 |
| PCT/RU2019/050123 WO2020027704A1 (ru) | 2018-08-03 | 2019-07-31 | Ингибиторы cdk8/19 |
| ARP190102200A AR115898A1 (es) | 2018-08-03 | 2019-08-02 | 1,7-naftiridinas como inhibidores de cdk8/19 |
| TW108127569A TWI839374B (zh) | 2018-08-03 | 2019-08-02 | Cdk8/19抑制劑 |
| CL2021000282A CL2021000282A1 (es) | 2018-08-03 | 2021-02-02 | Inhibidores de ckd8/19 |
| CONC2021/0001174A CO2021001174A2 (es) | 2018-08-03 | 2021-02-02 | Inhibidores de ckd8/19 |
| PH12021550258A PH12021550258A1 (en) | 2018-08-03 | 2021-02-03 | Cdk8/19 inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018128415A RU2761824C2 (ru) | 2018-08-03 | 2018-08-03 | Ингибиторы CDK8/19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018128415A RU2018128415A (ru) | 2020-02-04 |
| RU2018128415A3 true RU2018128415A3 (cg-RX-API-DMAC7.html) | 2021-03-30 |
| RU2761824C2 RU2761824C2 (ru) | 2021-12-13 |
Family
ID=69231230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018128415A RU2761824C2 (ru) | 2018-08-03 | 2018-08-03 | Ингибиторы CDK8/19 |
Country Status (19)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| CA3251059A1 (en) | 2022-05-02 | 2023-11-09 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions, systems and methods for modulating a target gene |
| WO2024109660A1 (zh) * | 2022-11-21 | 2024-05-30 | 上海齐鲁制药研究中心有限公司 | Cdk抑制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200808739A (en) | 2006-04-06 | 2008-02-16 | Novartis Vaccines & Diagnostic | Quinazolines for PDK1 inhibition |
| EP2229375A1 (en) | 2007-12-06 | 2010-09-22 | Schering Corporation | Gamma secretase modulators |
| EP2630122B1 (en) * | 2010-10-18 | 2016-11-30 | RaQualia Pharma Inc | Arylamide derivatives as ttx-s blockers |
| TWI529171B (zh) * | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | 1,7-萘啶衍生物 |
| JP2017522324A (ja) | 2014-07-17 | 2017-08-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 新規ナフチリジン及びイソキノリンならびにcdk8/19阻害剤としてのその使用 |
| EP3383875B1 (en) * | 2015-11-30 | 2022-02-09 | Council Of Scientific & Industrial Research | 3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof |
| EP3464267B1 (en) * | 2016-05-23 | 2020-09-23 | Boehringer Ingelheim International GmbH | New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors |
-
2018
- 2018-08-03 RU RU2018128415A patent/RU2761824C2/ru active
-
2019
- 2019-07-31 KR KR1020217006527A patent/KR102926889B1/ko active Active
- 2019-07-31 US US17/264,670 patent/US11840531B2/en active Active
- 2019-07-31 PE PE2021000162A patent/PE20210416A1/es unknown
- 2019-07-31 CA CA3108298A patent/CA3108298A1/en active Pending
- 2019-07-31 WO PCT/RU2019/050123 patent/WO2020027704A1/ru not_active Ceased
- 2019-07-31 EP EP19844331.9A patent/EP3831829A4/en active Pending
- 2019-07-31 CN CN201980065665.1A patent/CN113166140B/zh active Active
- 2019-07-31 MA MA52375A patent/MA52375B2/fr unknown
- 2019-07-31 JP JP2021505964A patent/JP7365396B2/ja active Active
- 2019-07-31 EA EA202190452A patent/EA202190452A1/ru unknown
- 2019-07-31 MX MX2021001335A patent/MX2021001335A/es unknown
- 2019-07-31 AU AU2019313199A patent/AU2019313199B2/en active Active
- 2019-07-31 BR BR112021001939-1A patent/BR112021001939A2/pt unknown
- 2019-08-02 AR ARP190102200A patent/AR115898A1/es unknown
- 2019-08-02 TW TW108127569A patent/TWI839374B/zh active
-
2021
- 2021-02-02 CL CL2021000282A patent/CL2021000282A1/es unknown
- 2021-02-02 CO CONC2021/0001174A patent/CO2021001174A2/es unknown
- 2021-02-03 PH PH12021550258A patent/PH12021550258A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102926889B1 (ko) | 2026-02-19 |
| CN113166140A (zh) | 2021-07-23 |
| AR115898A1 (es) | 2021-03-10 |
| MA52375B2 (fr) | 2023-02-28 |
| US11840531B2 (en) | 2023-12-12 |
| CL2021000282A1 (es) | 2021-08-13 |
| PH12021550258A1 (en) | 2021-10-11 |
| JP2021533143A (ja) | 2021-12-02 |
| CA3108298A1 (en) | 2020-02-06 |
| AU2019313199A1 (en) | 2021-03-11 |
| BR112021001939A2 (pt) | 2021-04-27 |
| WO2020027704A1 (ru) | 2020-02-06 |
| CO2021001174A2 (es) | 2021-02-26 |
| KR20210040416A (ko) | 2021-04-13 |
| CN113166140B (zh) | 2024-06-14 |
| RU2761824C2 (ru) | 2021-12-13 |
| EP3831829A1 (en) | 2021-06-09 |
| AU2019313199B2 (en) | 2023-07-06 |
| US20210246138A1 (en) | 2021-08-12 |
| PE20210416A1 (es) | 2021-03-04 |
| TW202012406A (zh) | 2020-04-01 |
| EP3831829A4 (en) | 2022-04-20 |
| TWI839374B (zh) | 2024-04-21 |
| EA202190452A1 (ru) | 2021-04-13 |
| RU2018128415A (ru) | 2020-02-04 |
| JP7365396B2 (ja) | 2023-10-19 |
| MX2021001335A (es) | 2021-04-12 |
| MA52375A1 (fr) | 2021-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021000792B8 (cg-RX-API-DMAC7.html) | ||
| AT524874A5 (cg-RX-API-DMAC7.html) | ||
| AT524834A2 (cg-RX-API-DMAC7.html) | ||
| AT521543A3 (cg-RX-API-DMAC7.html) | ||
| AT524961A5 (cg-RX-API-DMAC7.html) | ||
| AT524266A2 (cg-RX-API-DMAC7.html) | ||
| BR102019026286B1 (pt) | Método e aparelho para o avanço de produtos a serem moldados | |
| BR102019025884B1 (pt) | Sistema de segurança aprimorado para máquinas de operação de autopropulsão | |
| BR102019023514B1 (pt) | Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna | |
| BR112020016338B1 (pt) | Dispositivo para tratamento de tecido corporal | |
| BR112021001434B1 (pt) | Aço com alto teor de manganês e método de produção do mesmo | |
| BR112021001374B1 (pt) | Composição farmacêutica para o tratamento da hipertensão e seu uso | |
| BR112021001128B1 (pt) | Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit | |
| BR112021000922B1 (pt) | Tela de filtro, e, método para purificar água de alimentação | |
| BR112020026077B1 (pt) | Recipiente com estrutura encaixável | |
| BR112020026721B1 (pt) | Aparelho de moldagem para modar uma folha de um material contendo alcaloides | |
| BR102019012845B1 (pt) | Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga | |
| BR112020023832B1 (pt) | Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral | |
| BR112020022482B1 (pt) | Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico | |
| BR112020022658B1 (pt) | Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido | |
| BR112020021042B1 (pt) | Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas | |
| BR112020020812B1 (pt) | Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado | |
| BR112020015757B1 (pt) | Métodos, sistema, kit e dispositivos para visualização e remoção de tumor | |
| BR102019000241B1 (pt) | Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados | |
| BR102018073077B1 (pt) | Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue |